You are here:

  1. NICE
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Obesity

Tirzepatide for managing overweight and obesity

  • Technology appraisal guidance
  • Reference number: TA1026
  • Published:  23 December 2024
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Resource impact
  2. Implementation support
  3. Guidance into practice

Tools and resources

Tools to help you put the guidance into practice.

Resource impact

  • Resource impact summary report

  • Resource impact template (Excel 1 MB)

    Published:
    23 December 2024
  • Resource impact template

Implementation support

  • Tirzepatide: local formulary information

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance